Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34results about How to "Valid mark" patented technology

N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine translation system and application thereof

The invention relates to an aminoacyl-tRNA (transfer ribonucleic acid) synthetase mutant containing an amino acid sequence selected from groups consisting of amino acids shown by SEQ ID NO:4 and conservative variants thereof. The invention provides a CpK (short for N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine) translation system for fixed point specific insertion of N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine in a target protein through pairing of orthogonal tRNA and orthogonal aminoacyl-tRNA synthetase, and a method for fixed point specific insertion of CpK in the target protein by using the translation system. The CpK translation system comprises (i) N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine, (ii) the orthogonal aminoacyl-tRNA synthetase, (iii) the orthogonal tRNA and (iv) a nucleic acid for coding the target protein, wherein the orthogonal aminoacyl-tRNA synthetase is used for realizing aminoacylation of the orthogonal tRNA preferentially by using CpK, and the nucleic acid contains at least one selective codon specifically identified by the orthogonal tRNA. The invention also relates to an application of a mutant protein for fixed point specific insertion of CpK in protein labeling through a light click reaction with a tetrazole compound.
Owner:INSITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES

Application of ruthenium complex modified nano selenium in promotion of mesenchymal stem cell in-vitro osteoblast differentiation

InactiveCN104017769AInhibit adipogenic differentiationValid markSkeletal/connective tissue cellsEmbryonic cellsProduct systemOsteoblast
The invention belongs to the technical field of promotion of mesenchymal stem cell in-vitro osteoblast differentiation, and discloses an application of ruthenium complex modified nano selenium in promotion of mesenchymal stem cell in-vitro osteoblast differentiation. The invention provides the application of the ruthenium complex modified nano selenium in promotion of mesenchymal stem cell in-vitro osteoblast differentiation. The nano selenium can promote the mesenchymal stem cell in-vitro osteoblast differentiation of human umbilical cord, the differentiation balance is exsited between the mesenchymal stem cell ossification differentiation and esterification differentiation, so that the nano selenium has the effect for inhibiting esterification differentiation of mesenchymal stem cells, and can effectively labeling the mesenchymal stem cell. According to the invention, a ruthenium complex is used for modifying nano selenium, other auxiliary reagents are required for adding during a preparation process, the products system is simple, and the product can be directly preserved and used. The employed modification agent can greatly reduce the cytotoxicity of the ruthenium complex modified nano selenium, usage amount of the medicine for cells can be increased, external discharge is reduced, and the medicine in the cell can keep as a high level.
Owner:JINAN UNIVERSITY

Digital restoration method for flaking diseases of ancient wall paintings based on compressed sensing, and intelligent terminal system

The invention discloses a digital restoration method for flaking diseases of ancient wall paintings based on compressed sensing, and an intelligent terminal system. The method employs a wall painting image preprocessing module, a wall painting flaking disease marking module and a wall painting image restoration module. The method comprises the steps: enabling the wall painting image preprocessing module to carry out the image denoising and HSV color space transformation, enabling the wall painting flaking disease marking module to achieve the V component extraction of a wall painting image, drawing a brightness contour map through a contour function, carrying out the threshold segmentation of the brightness contour map, and obtaining wall painting segmented images; obtaining a closed interval of a disease region through the morphological corrosion operation, carrying out the overlapping of the segmented images and a damaged wall painting image, and marking the flaking disease region of the wall painting; enabling the wall painting image restoration module to carry out the restoration of the flaking disease region of the wall painting through an image restoration algorithm based on compressed sensing of a PMLE mechanism and an EM mechanism. The method can independently complete the marking of the flaking disease region in the ancient wall painting and the intelligent restoration, and provides support for the digital virtual display of the wall painting.
Owner:XI'AN UNIVERSITY OF ARCHITECTURE AND TECHNOLOGY

Markable dark red fluorescent active ester

The invention belongs to the field of fluorescent imaging reagents and relates to a dark red fluorescent active ester IR640B-NHS which can be rapidly marked, and a precursor IR640B of the ester. According to the ester, 2,3,3-trimethylindole is adopted as a matrix which reacts with raw materials such as butane sultone, then a cyanine type fluorescent group with a sulfonic group is synthesized, further through a Suzuki-Miyaura reaction, phenyl carboxylic acid is introduced into a fluorescent group through a carbon-carbon bond, and the phenyl carboxylic acid is modified to generate an N-hydroxylcarboxyfluorescein diacetate succinimidyl ester. The active ester can react with a primary amino group in biological macromolecules under physiological conditions, and then dark red fluorescent groupscan be marked on target molecules through amide bonds. By adopting the ester, biological macromolecules such as polypeptide, proteins, antibodies or polymer molecules can be rapidly, safely, effectively and stably marked, in-vitro evaluation on acceptor targeting properties and intracellular distribution of target biological macromolecules can be implemented by using a fluorescence microscope, aflow cytometer and the like, and nondestructive monitoring and quantitative tracing on target molecules can be achieved through living optical imaging.
Owner:FUDAN UNIV

Separation method of human intervertebral disc PROCR < + > nucleus pulposus progenitor cells

PendingCN114107183APromotes clonogenicityPromote self-renewalCell dissociation methodsSkeletal disorderStainingMagnetic bead
The invention provides a method for separating human intervertebral disc PROCR < + > nucleus pulposus progenitor cells, which comprises the following steps of: 1) fully cutting nucleus pulposus into pieces, and sequentially and respectively digesting the nucleus pulposus pieces with trypsin, streptavidin and type II collagenase to obtain a cell suspension; 2) carrying out erythrocyte splitting decomposition treatment on the cell suspension, carrying out magnetic bead sorting to remove tissue impurities, and resuspending cells with PBS + 0.04% BSA to obtain a cell resuspension; and 3) dyeing the cells in the cell resuspension with PROCR flow cytometry antibodies, sorting through a flow cytometry, comparing the sorting efficiency of two mainstream PROCR clone number antibodies, optimizing the sorting scheme, and finally obtaining the human intervertebral disc PROCR + nucleus pulposus progenitor cells. The invention also provides the human intervertebral disc PROCR < + > nucleus pulposus progenitor cell obtained according to the separation method and application thereof. The nucleus pulposus PROCR < + > cells prepared by the invention have good clone formation, self-renewal and three-line differentiation capacities, and a brand new seed cell source is provided for a biological treatment strategy of intervertebral disc degenerative diseases.
Owner:中国人民解放军陆军特色医学中心

Application of ruthenium complex modified nano-selenium in promoting osteogenic differentiation of mesenchymal stem cells

InactiveCN104017769BInhibit adipogenic differentiationValid markSkeletal/connective tissue cellsEmbryonic cellsProduct systemOsteoblast
The invention belongs to the technical field of promotion of mesenchymal stem cell in-vitro osteoblast differentiation, and discloses an application of ruthenium complex modified nano selenium in promotion of mesenchymal stem cell in-vitro osteoblast differentiation. The invention provides the application of the ruthenium complex modified nano selenium in promotion of mesenchymal stem cell in-vitro osteoblast differentiation. The nano selenium can promote the mesenchymal stem cell in-vitro osteoblast differentiation of human umbilical cord, the differentiation balance is exsited between the mesenchymal stem cell ossification differentiation and esterification differentiation, so that the nano selenium has the effect for inhibiting esterification differentiation of mesenchymal stem cells, and can effectively labeling the mesenchymal stem cell. According to the invention, a ruthenium complex is used for modifying nano selenium, other auxiliary reagents are required for adding during a preparation process, the products system is simple, and the product can be directly preserved and used. The employed modification agent can greatly reduce the cytotoxicity of the ruthenium complex modified nano selenium, usage amount of the medicine for cells can be increased, external discharge is reduced, and the medicine in the cell can keep as a high level.
Owner:JINAN UNIVERSITY

nε-(1-methylcycloprop-2-enamide)-lysine translation system and its application

The invention relates to an aminoacyl-tRNA (transfer ribonucleic acid) synthetase mutant containing an amino acid sequence selected from groups consisting of amino acids shown by SEQ ID NO:4 and conservative variants thereof. The invention provides a CpK (short for N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine) translation system for fixed point specific insertion of N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine in a target protein through pairing of orthogonal tRNA and orthogonal aminoacyl-tRNA synthetase, and a method for fixed point specific insertion of CpK in the target protein by using the translation system. The CpK translation system comprises (i) N<epsilon>-(1-methylcyclopropyl-2-acrylamide)-lysine, (ii) the orthogonal aminoacyl-tRNA synthetase, (iii) the orthogonal tRNA and (iv) a nucleic acid for coding the target protein, wherein the orthogonal aminoacyl-tRNA synthetase is used for realizing aminoacylation of the orthogonal tRNA preferentially by using CpK, and the nucleic acid contains at least one selective codon specifically identified by the orthogonal tRNA. The invention also relates to an application of a mutant protein for fixed point specific insertion of CpK in protein labeling through a light click reaction with a tetrazole compound.
Owner:INSITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES

Method and system for recognizing fault of chemical process

The disclosure puts forward a method and a system for recognizing a fault of a chemical process, which are applied to the field of expensive label chemical fault recognition. The method and the systemare characterized in that: a dynamic active safety semi-supervised support vector machine model (PCA-DAS4VM model for short) is used for recognizing an operation state of the chemical process, a principal component analysis method is combined with the dynamic active safety semi-supervised support vector machine, the requirement of traditional supervised learning on the number of label data is made up, and recognition accuracy of the semi-supervised learning is improved; the principal component analysis method is adopted to eliminate noise and redundant data in the chemical process, abnormal working condition fault recognition is performed by combination between historical information and future information, unmarked data with high entropy is effectively selected and marked, the unmarked data is fully utilized to improve the performance of a recognizing model, efficient and complete fault recognization operation in the chemical process is realized, the recognization accuracy is high, and the recognization speed is quick, so that the development of chemical safety is promoted.
Owner:QINGDAO UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products